Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Swift

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Annals of the New York Academy of Sciences|January 1, 1988
Substituted 5-phenoxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidines. Antifungal activity and structure-activity relationship studiesG B Mullen, D M Maryniak, P A Swift, et al.
Annals of the New York Academy of Sciences|January 1, 1988
cis-3-(substituted phenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-([(substituted phenyl)thio(or amino)]methyl)isoxazolidines. In vitro antifungal activity and structure-activity relationshipsT R DeCory, P A Swift, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
3-(substituted phenyl)-3-(1H-1,2,4-triazol-1-ylmethyl)-2-methyl-5- [(substituted phenoxy)methyl]-isoxazolidine derivatives. Structure-activity relationshipsG A Bennett, P A Swift, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
cis-5-alkyl(or alkenyl)-3-phenyl-3-(1H-imidazole-1-ylmethyl)-2- methylisoxazolidine derivatives. In vitro antifungal activity and structure-activity relationshipsP A Swift, G A Bennett, G B Mullen, et al.
Kidney International Reports|March 26, 2026
Managing Blood Pressure in Dialysis Patients: A Summary of UK Clinical Practice GuidelineI Dasgupta, M Adam, K Durman, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Annals of the New York Academy of Sciences|January 1, 1988
Substituted 5-phenoxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidines. Antifungal activity and structure-activity relationship studiesG B Mullen, D M Maryniak, P A Swift, et al.
Annals of the New York Academy of Sciences|January 1, 1988
cis-3-(substituted phenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-([(substituted phenyl)thio(or amino)]methyl)isoxazolidines. In vitro antifungal activity and structure-activity relationshipsT R DeCory, P A Swift, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
3-(substituted phenyl)-3-(1H-1,2,4-triazol-1-ylmethyl)-2-methyl-5- [(substituted phenoxy)methyl]-isoxazolidine derivatives. Structure-activity relationshipsG A Bennett, P A Swift, G B Mullen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
cis-5-alkyl(or alkenyl)-3-phenyl-3-(1H-imidazole-1-ylmethyl)-2- methylisoxazolidine derivatives. In vitro antifungal activity and structure-activity relationshipsP A Swift, G A Bennett, G B Mullen, et al.
Kidney International Reports|March 26, 2026
Managing Blood Pressure in Dialysis Patients: A Summary of UK Clinical Practice GuidelineI Dasgupta, M Adam, K Durman, et al.
Pageof 2